K-ATP

钾-ATP

• 批准号: 7608084
• 负责人: DANIEL C STEIN
• 金额: $ 1.53万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-02-15 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7608084
• 关键词: Adipose tissue; Computer Retrieval of Information on Scientific Projects Database; Diazoxide; Funding; Grant; Hepatic; Institution; Insulin Resistance; Non-Insulin-Dependent Diabetes Mellitus; Obesity; Peripheral; Randomized Controlled Clinical Trials; Research; Research Personnel; Resources; Source; United States National Institutes of Health; insulin sensitivity

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a randomized trial of the effects of K-ATP channel inhibition via the K-ATP channel activator diazoxide on hepatic, peripheral and adipose insulin sensitivity in normal subjects, subjects with obesity and insulin resistance and subjects with Type 2 diabetes.

这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这是一项在正常受试者、肥胖和胰岛素抵抗受试者以及2型糖尿病受试者中通过K-ATP通道激活剂二氮嗪抑制K-ATP通道对肝脏、外周和脂肪胰岛素敏感性的影响的随机试验。